Resources

This brief provides a clinical overview of the injectable contraceptive subcutaneous DMPA (DMPA-SC or Sayana® Press), which contains 30% less depot medroxyprogesterone acetate than the intramuscular presentation of Depo-Provera®. DMPA-SC is administered subcutaneously through the prefilled Uniject injection system, an autodisable injection device. For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

This fact sheet describes PATH’s Center for Vaccine Innovation and Access (CVIA), which was launched in 2016 to strengthen, accelerate, and coordinate PATH’s broad range of work across the vaccine spectrum.

Fact sheet for pre-eclampsia diagnostic test

PATH joined the Global Health Security effort, led by the US Centers for Disease Control and Prevention to advance the US government’s pledge to support countries in fighting infectious diseases through surveillance, and building laboratory and health information systems capacity.

PATH, a global leader in maternal, newborn, and child health and nutrition, partners with communities, governments, and stakeholders to address malnutrition worldwide. This fact sheet introduces our Nutrition Innovation Initiative, a unique “idea incubator��? that links nutrition solutions from across sectors to further expand our impact.